The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Alexza Pharmaceuticals Inc | COM | 015384100 | 1,133 | 247,812 | SH | SOLE | 247,812 | 0 | 0 | ||
Anacor Pharmaceuticals Inc | COM | 032420101 | 27,411 | 1,545,999 | SH | SOLE | 1,545,999 | 0 | 0 | ||
BioCryst Pharmaceuticals Inc | COM | 09058V103 | 22,241 | 1,744,356 | SH | SOLE | 1,744,356 | 0 | 0 | ||
DBV Technologies | COM | F2927N109 | 12,451 | 480,000 | SH | SOLE | 480,000 | 0 | 0 | ||
Dyax Corp | COM | 26746E103 | 19,208 | 2,000,859 | SH | SOLE | 2,000,859 | 0 | 0 | ||
Flamel Technologies S.A. | COM | 338488109 | 7,500 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
GW Pharmaceuticals | COM | 36197T103 | 33,459 | 311,853 | SH | SOLE | 311,853 | 0 | 0 | ||
Heron Therapeutics Inc | COM | 427746102 | 13,499 | 1,095,734 | SH | SOLE | 1,095,734 | 0 | 0 | ||
Keryx Biopharmaceuticals Inc | COM | 492515101 | 10,770 | 700,273 | SH | SOLE | 700,273 | 0 | 0 | ||
Lipocine Inc | COM | 53630X104 | 867 | 142,100 | SH | SOLE | 142,100 | 0 | 0 | ||
Neurocrine Biosciences Inc | COM | 64125C109 | 4,502 | 303,503 | SH | SOLE | 303,503 | 0 | 0 | ||
Ocera Therapeutics | COM | 67552A108 | 5,376 | 703,730 | SH | SOLE | 703,730 | 0 | 0 | ||
OHR Pharmaceutical | COM | 67778H200 | 4,536 | 477,000 | SH | SOLE | 477,000 | 0 | 0 | ||
Radius Health Inc | COM | 750469108 | 6,825 | 525,000 | SH | SOLE | 525,000 | 0 | 0 | ||
TherapeuticsMD Inc | COM | 88338N107 | 3,742 | 846,500 | SH | SOLE | 846,500 | 0 | 0 | ||
Zafgen Inc | COM | 98885E103 | 10,710 | 541,480 | SH | SOLE | 541,480 | 0 | 0 | ||
ZS Pharma Inc | COM | 98979G105 | 2,875 | 100,000 | SH | SOLE | 100,000 | 0 | 0 |